Somatostatin Imaging of Neuroendocrine-Differentiated Prostate Cancer

被引：1
|
作者：
Hope, Thomas A. [1 ]
Aggarwal, Rahul [2 ]
Simko, Jeff P. [3 ,4 ,5 ]
VanBrocklin, Henry F. [1 ]
Ryan, Charles J. [2 ]
机构：
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Div Hematol Oncol, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2015年 / 40卷 / 06期
关键词：
prostate cancer; octreotide; neuroendocrine; somatostatin; FDG;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
After prolonged androgen deprivation therapy, a subset of castrate-resistant prostate cancer patients will develop neuroendocrine prostate cancer (NEPC) associated with resistance to further hormonal therapy and frequent visceral metastases. Imaging the presence of somatostatin receptors on the cancer cell surface may provide a readily available, noninvasive means to distinguish adenocarcinoma from NEPC. This distinction is important for therapeutic decision making and may open the door for developing novel radionuclide targets for the treatment of this aggressive subtype of prostate cancer. We describe a case of NEPC successfully imaged using In-111-labeled octreotide.
引用
收藏
页码：540 / 541
页数：2
相关论文
共 50 条
  • [21] The use of somatostatin analogues in metastatic hormone refractory and chemoresistant prostate cancer with neuroendocrine differentiation
    Intrivici, Chiara
    Vizzini, Laura
    Travagliato, Maria Grazia
    Pizzo, Tommaso
    Badalamenti, Giuseppe
    Arcara, Carlo
    Cicero, Giuseppe
    Rinaldi, Gaetana
    Crosta, Adele
    Spinnato, Francesca
    Valerio, Maria Rosaria
    Gebbia, Nicola
    Fulfaro, Fabio
    ANNALS OF ONCOLOGY, 2005, 16 : 81 - 81
  • [22] Somatostatin Receptor Imaging PET in Neuroendocrine Neoplasm
    Johnbeck, Camilla Bardram
    Mortensen, Jann
    PET CLINICS, 2021, 16 (02) : 191 - 203
  • [23] Neuroendocrine Prostate Cancer: Report of a Prostate Cancer Subtype with Atypical Metastatic Imaging and Clinical Findings
    Nixon, Bryan
    Aher, Pritish
    JOURNAL OF RADIOLOGY CASE REPORTS, 2024, 18 (05): : 17 - 23
  • [24] Biomarkers and Novel PET Imaging to Detect Neuroendocrine Prostate Cancer
    Aggarwal, Rahul
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (01) : 16 - 17
  • [25] Molecular Imaging of Neuroendocrine Differentiation of Prostate Cancer: A Case Series
    Iravani, Amir
    Mitchell, Catherine
    Akhurst, Tim
    Sandhu, Shahneen
    Hofman, Michael S.
    Hicks, Rodney J.
    CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : E200 - E205
  • [26] Endogenous H2S augments secretory functions via activation of Cav3.2 T-type Ca2+ channels in neuroendocrine-differentiated prostate cancer cells
    Fukami, Kazuki
    Kasamatsu, Ryuji
    Yoshida, Shigeru
    Sekiguchi, Fumiko
    Kawabata, Atsufumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 92P - 92P
  • [27] Differentiated Thyroid Cancer: A New Perspective with Radiolabeled Somatostatin Analogues for Imaging and Treatment of Patients
    Versari, Annibale
    Sollini, Martina
    Frasoldati, Andrea
    Fraternali, Alessandro
    Filice, Angelina
    Froio, Armando
    Asti, Mattia
    Fioroni, Federica
    Cremonini, Nadia
    Putzer, Daniel
    Erba, Paola Anna
    THYROID, 2014, 24 (04) : 715 - 726
  • [28] Neuroendocrine prostate cancer
    Tritschler, S.
    Erdelkamp, R.
    Stief, C.
    Hentrich, M.
    UROLOGE, 2017, 56 (11): : 1475 - 1483
  • [29] Neuroendocrine prostate cancer
    Tritschler, S.
    Erdelkamp, R.
    Stief, C.
    Hentrich, M.
    PATHOLOGE, 2018, 39 (04): : 333 - 341
  • [30] Neuroendocrine prostate cancer
    Kretschmer, A.
    Wittekind, C.
    Stief, C. G.
    Gratzke, C.
    UROLOGE, 2015, 54 (12): : 1779 - 1783
12345